MedCity Influencers

4 ways the pandemic has shaped healthcare

  • by

While the long-term impacts of Covid-19 are still unfolding, here are four ways hospitals and health systems are beginning to understand the monumental impact of the pandemic on the healthcare industry.  

Healthcare tech is failing patients

  • by

The problem is that we’re approaching technology from a clinical and billing perspective, with little input from patients. We must demand and implement technology that is designed for the population you are serving.

Here’s a look at natural product drug discovery 2.0

  • by

Plant-based drug discovery may be tens of thousands of years old, but in 2021, it feels exciting, rich, and full of potential. Companies are rapidly building scalable databases with hundreds of thousands of unique chemicals and their links to biological signatures.

Infusing call centers with strong human connections

  • by

The volume of calls to hospital call centers has led to an industrialized approach thereby sacrificing the human touch and personal connection between doctors and patients. Ironically, artificial intelligence can help to rekindle that by handling call center calls more efficiently.

The Key to SDOH: Health literacy

  • by

As a country, we must do a better job supporting people and communities throughout their health journey because communities with greater access to information and increased levels of health literacy will ensure better health outcomes.

3 changes coming to drug pricing

  • by

No matter if Democrats or Republicans are running the show in Washington, here are three solid bets for pharma companies to plan for in the changing drug-pricing landscape

How eConsent empowers more participant engagement in clinical trials

  • by

Creating the simplest process for informed consent benefits the potential participant by allowing them the time and resources to understand fully what they are consenting to. Through eConsent processes, research also opens the door to a more diverse population to engage in trials.

How to overcome AI’s healthcare headwinds

  • by

AI has already shown tremendous promise for everything from automating patient communication and non-clinical administrative tasks to reducing physician burnout. But realizing that promise more broadly requires AI developers to establish trust with their healthcare users.

How to build a diverse innovation team (and why it’s critical)

  • by

Why start with innovation? Because it’s where the products, tools, solutions, and ideas that will change the status quo are born. Without diversity of thought, experience, and perspective, the end result of innovation only serves those already at the table.

5 AI lessons from pharma world learned during Covid-19

  • by

With the increased reliance on digital technologies, pharma companies’ outreach to healthcare providers needs to be thoughtful, efficient, and respectful. An AI-driven, omnichannel strategy makes this possible by giving every member of customer-facing teams visibility across communications.

Amazon Care and privacy: A host of unknowns

  • by

If HIPAA does not apply to Amazon Care, then absent another privacy regulation applying, avoiding exploitation of the data relies on the good faith of the entity operating the service.

Suicide and the malpractice myth

  • by

It may seem intuitive to avoid telehealth or remote care to avoid increased liability and malpractice exposure. But remote behavioral health assessment tools, real-time data-driven insights, and adaptive treatment plans are actually the things that protect clinicians from civil liability in instances of patient suicide.

Antibody testing can improve efficiency in limited vaccine supply

  • by

Given our current limited supply, the threat of variant spread, and availability of higher quality antibody test kits, policymakers ought to update their vaccine guidance for those who had Covid and incorporate recent research findings on immunity and vaccine efficacy.

Addressing the Covid-19 and Opioid “Twindemic”

  • by

The past year has taught everyone the value of a more compassionate and non-punitive approach toward just about everything. Now, it’s time for leaders to take that approach and apply it, with supportive data and knowledge, to mitigating opioid addiction in their communities.

Blockchains are the building blocks of better healthcare

  • by

Rather than having multiple digital ledgers for the industry, better health care results require a single global blockchain that massively scales, capable of efficiently handling high volumes of data to act as the single source for information.

One-size-fits-all addiction treatment must be replaced

  • by

While addiction treatment has traditionally focused on the removal of substance use ‘symptoms’ by collecting urine samples and screening for substance use, the complexity of the biopsychosocial framework requires commensurate measurement tooling.

4 signs your compliance program is out of date

  • by

Many players in life sciences and other sectors balk at updating their compliance systems because of the cost and resources involved. but addressing possible lapses now can save your company millions of dollars in fines and reputational damage.

Does digital mental health need to rethink user engagement?

  • by

Gamification is being hailed as a promising tool within the digital mental health industry. But should the same tactics that are fueling our online addiction become the standard for driving engagement with solutions that are designed to improve our mental health?

HHS Prep Act amendment could fail the nurses it aims to support

  • by

The HHS amendment is meant to vaccinate Americans as quickly as possible.  This could be an incredible turning point in offering additional support for our frontline workforce or, if not executed correctly, could add additional and unnecessary stress to a field already experiencing widespread burnout.

The year to come in life sciences safety and regulatory practices

  • by

The life sciences industry will move toward more agile capabilities for regulatory operations and regulators toward an accelerated approval pathway in support of clinical studies, drawing from lessons learned during the pandemic around global collaboration.

With Covid vaccines, are we out of the woods? Not quite

  • by

Covid vaccines are the talk of the town but in the meantime, there remains a great need for Covid-19 management solutions – including effective screening, efficient testing, improving treatments, battling vaccine misinformation, continued mask-wearing and social distancing – to protect the public.

The Home health landrush: Getting ahead in a complex market

  • by

Few people question whether care delivery will continue to migrate out of the hospital into new settings such as the home. The better question is, what services – specifically – will migrate to the home, and what innovations are necessary to support these migrations?

How Covid-19 is accelerating interoperability

  • by

The combination of regulatory pressure and technological advances will help move the needle forward — and not just for the sake of better interoperability, but also to get the Covid-19 pandemic under control and improve the health and wellbeing of us all.

How AI is reshaping the future of the patient-provider experience

  • by

We’re only just beginning to learn how to harness the power of AI in ways that cultivate stronger healthcare systems — and ensure that the value of connection akin to the human condition is not lost but rather nurtured in its use among healthcare providers.

Under one roof: How to treat autism in children

  • by

The need and demand for access to quality, interdisciplinary therapy will only continue to grow. Early intervention, with consistent, qualified care provided under one roof, can generate better outcomes that will help children and their families change what autism means in their lives.

The bot will see you now

  • by

Using natural-language processing and speech recognition technologies, startups are now creating chat-bots and other apps that can, to a remarkable extent, accurately replicate the experience of chatting with a receptionist or nurse.

Getting healthcare enterprise AI data to deliver

  • by

When we talk about artificial intelligence, the truth is most physicians aren’t using it.What we need now is for developers and tech executives to stop designing theoretical solutions, and instead place physicians, patients, and specific clinical needs at the center of their solutions.

Predictive surveillance: Can artificial intelligence eliminate HAIs?

  • by

AI-powered surveillance systems are helping health systems and public health agencies with their response to the Covid-19 pandemic. The current health crisis offers a glimpse of how it may be possible to predict and prevent a range of chronic health concerns, including healthcare-associated infections.

How to improve revenue cycle management: 5 tips

  • by

Especially in a tough economic climate, healthcare facilities need more efficient ways to improve cash flow and remain stable by ensuring claims are accurately processed and quickly paid. 

In the uncompensated care pandemic, AI is a potent antidote

  • by

By helping patients find affordable healthcare, AI will promote stronger financial health for providers and patients alike, and improve the quality of care as patients gain the financial support to engage in more preventative healthcare.

Why we need a wholistic approach to behavioral health

  • by

I’m not proud to say that in the past, I’ve played a role in cutting behavioral health programs in an effort to navigate budget constraints and mitigate financial losses. But my perspective as a finance executive is not what it used to be.

Ransomware in healthcare: The inevitable truth

  • by

The best path forward for healthcare organizations is first to understand the characteristics, causes, and indicators of ransomware attacks and then be proactive in taking preventative measures.

Here are the benefits of data consolidation

  • by

Data consolidation and a modern approach to data management across health care organizations are critical for driving operational efficiency, protecting critical patient data and, most importantly, delivering optimal health outcomes.

Staying sane on the mission to Mars

  • by

Recently, the Translational Research Institute for Space Health selected three innovative biotech companies using VR, conversation-bots, and probiotic therapeutics to combat mental health risks.

Technology can ease pandemic challenges faced by hospitals, ambulatory surgery centers

  • by

To keep critical revenue flowing, hospitals and ambulatory surgery centers need to resume elective surgeries and procedures as quickly as possible and mobile apps can help by giving patients and staff vital information, provide advance symptom screening and help providers reduce elective procedure no-shows through… Read More »Technology can ease pandemic challenges faced by hospitals, ambulatory surgery centers

The new frontline of care: social services

  • by

Radically improving health outcomes for vulnerable populations requires a multifaceted proactive, community-wide approach focused on better understanding social determinants of health and simultaneously addressing social and health inequalities.

How the value of innovation will be redefined in 2021

  • by

While payers and policymakers took a more narrow-minded perspective on innovation value in 2020, the year 2021 will bring an increased focus on a treatment’s societal value, how innovation interacts with digital technologies, and whether new innovations are able to reduce existing health outcome inequalities.

Realizing healthcare’s robotic revolution

  • by

Trained clinical judgment and human compassion will always be irreplaceable, but robotics and automation can also provide predictable and repeatable movements, facilitating better standardization of treatment, which allows physicians to focus on clinical decision making.

The importance of care coordination

  • by

While providers diagnose and treat in the hospital, care coordinators go beyond the four walls of that facility, into the community, and meet patients where they are, both literally and figuratively.

After the pandemic, hospitals should keep working together

  • by

We’re beating Covid-19 by sharing resources. Why stop there? By pooling select healthcare resources, we could also collectively buy supplies in bulk, lowering costs for everyone and minimizing our exposure to supply chain disruptions after the pandemic.

The e-doctor will see you now

  • by

Fully-credentialled e-doctors still don’t exist, at least not in their entirety but major elements of the concept have already been deployed in the field, and progress toward a more comprehensive e-doc is well underway.

Why geriatric care must evolve post-Covid-19

  • by

Even relatively healthy older adults see the benefit of receiving home-based primary care, not just because of its convenience, but because patients feel safer at home now, and more unsafe than ever in ambulatory settings surrounded by other sick patients. 

What would post-Covid value-based care look like?

  • by

As virtual care is only going to grow in the coming months as a solution to pent-up demand for care that has resulted from the pandemic, focused attention is needed to address these operational and reimbursement issues.

Why we invested in Eden Health

  • by

Flare Capital Partner Dan Gebremedhin explains what led the venture capital firm to invest in New York-based Eden Health and lead its recent Series B round.

How wearables can help the healthcare industry address Covid-19

  • by

The potential that wearables have for helping detect early signs of Covid-19 and other infectious diseases, as well as monitoring patients, will make this technology a popular choice for healthcare organizations and consumers for the foreseeable future.

Trust, privacy, and our American pandemic 

  • by

Health information exchanges know about the hard work of building trust by delivering value in healthcare. They have been in these trenches. They need a seat at the table with our state public health leaders as America works to safely reopen.

Are we experiencing a natural selection moment in health tech?

  • by

Health tech companies in the wellness industry might face a more difficult market than those in the clinical-grade domain. Benefits offered by wellness companies are those most likely to be viewed as nice-to-have perks that may not bring enough value. 

A brief history of the future of genomics

  • by

Naysayers have been proven wrong multiple times over as companies across the biotech industry have advanced to deliver diagnostics and detection assays across a number of different cancer types enabling predictive testing, early diagnosis and objective results.

The critical need for community investment

  • by

In comparison to other developed countries, we spend the least amount of money on social care and the most on medical, with the worst overall health outcomes. We must intentionally and strategically reallocate some healthcare dollars to invest in communities.